Почетна › Рак дојке › Misuri › St. Louis
Kliničke studije za Рак дојке u gradu St. Louis, MO
63 studija za Рак дојке traži učesnike na lokacijama u gradu St. Louis i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
WashU DIEP Flap Video and Patient Understanding Improvement
Тражи се учесник
- Washington University School of Medicine, St Louis
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Тражи се учесникФаза 3
- Washington University School of Medicine, St Louis
An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- Washington University in St Louis, St Louis
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Тражи се учесникФаза 3
- Saint Louis Cancer and Breast Institute-South City, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- и још 2
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Тражи се учесникФаза 1/2
- Research Facility, St Louis
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Тражи се учесникФаза 1/2
- Washington University School of Medicine, St Louis
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Тражи се учесникФаза 3
- Washington University Siteman Cancer Center ( Site 0031), St Louis
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Тражи се учесникФаза 2
- Washington University School of Medicine- Siteman Cancer Center, St Louis
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- Washington University School of Medicine, St Louis
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- Washington University, St Louis
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Тражи се учесник
- Mercy Health - Sindelar Cancer Center, St Louis
- Mercy Health - Pratt Cancer Center, St Louis
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Тражи се учесникФаза 3
- Washington University School of Medicine- Siteman Cancer Center, St Louis
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Тражи се учесникФаза 3
- Cancer Care Specialists of Central Illinois, O'Fallon · 16 ми удаљено
E-Mindfulness Approaches for Living After Breast Cancer
Тражи се учесникФаза 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- и још 1
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Тражи се учесникФаза 2
- Washington University School of Medicine, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- и још 4
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Тражи се учесникОпсервациона студија
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- и још 4
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Тражи се учесникФаза 1
- Washington University School of Medicine in St. Louis, St Louis
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Тражи се учесникФаза 1
- Washington University, St Louis
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Тражи се учесникФаза 3
- Mercy Infusion Center - Chippewa, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- и још 9
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
Тражи се учесник
- Washington University School of Medicine, St Louis
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Тражи се учесникОпсервациона студија
- Washington University School of Medicine, St Louis
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Тражи се учесникФаза 3
- Cancer Care Specialists of Illinois, O'Fallon · 16 ми удаљено
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Тражи се учесникФаза 1
- Washington University, Siteman Cancer Center, St Louis
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Тражи се учесникФаза 1/2
- Washington Univ. School of Medicine, St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 2
- Washington University, School of Medicine, St Louis
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Тражи се учесникФаза 1/2
- Washington University Siteman Cancer Center, St Louis
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health
Тражи се учесник
- Washington University School of Medicine, St Louis
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Тражи се учесникФаза 3
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- и још 6
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Тражи се учесникФаза 1
- Washington University School of Medicine, St Louis
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Тражи се учесникФаза 1/2
- Washington University School of Medicine, St Louis
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Тражи се учесникФаза 3
- Washington University School of Medicine ( Site 0076), St Louis
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Тражи се учесникФаза 1/2
- Research Site, St Louis
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Тражи се учесникФаза 3
- Washington University School of Medicine in Saint Louis, St Louis
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
Тражи се учесник
- Washington University School of Medicine, St Louis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Тражи се учесникФаза 1
- Washington University School of Medicine, St Louis
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Тражи се учесникФаза 2
- Washington University School of Medicine, St Louis
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Тражи се учесникФаза 3
- Research Site, St Louis
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Local Institution - 0140, St Louis
Precision Supplemental Imaging in Women With Dense Breasts
Тражи се учесникЗдраве особе су добродошле
- Washington University School of Medicine, St Louis
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- Washington University School of Medicine, St Louis
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- Washington University School of Medicine, St Louis
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Тражи се учесникОпсервациона студија
- Cancer Care Specialist of Illinois, O'Fallon · 16 ми удаљено
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Тражи се учесникФаза 1/2
- WA Uni School Of Med, St Louis
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Тражи се учесникФаза 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- и још 4
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Тражи се учесникФаза 1
- Washington University School of Medicine, St Louis
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Тражи се учесникФаза 3
- Siteman Cancer Center - Washington University Medical Campus, St Louis
IDOV-Immune for Advanced Solid Tumors
Тражи се учесникФаза 1
- Washington University School of Medicine, St Louis
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Тражи се учесникФаза 2
- Washington University School of Medicine, St Louis
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Тражи се учесникФаза 2
- Washington University School of Medicine, St Louis
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Investigative Site #110, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Washington University, St Louis
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
Тражи се учесник
- Washington University School of Medicine, St Louis
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
Тражи се учесникОпсервациона студија
- Washington University School of Medicine, St Louis
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Тражи се учесникФаза 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- и још 3
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Тражи се учесникФаза 2
- Washington University School of Medicine, St Louis
Cryoablation vs Lumpectomy in T1 Breast Cancers
Тражи се учесник
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Washington University School of Medicine, St Louis
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer
Тражи се учесникФаза 2
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, St Louis
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Тражи се учесникФаза 1
- Washington University School of Medicine St. Louis, St Louis
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Тражи се учесникОпсервациона студија
- Washington University School of Medicine, St Louis
Studije za Рак дојке u drugim gradovima
- New York City, NY144 студија
- Houston, TX126 студија
- Boston, MA110 студија
- Nashville, TN78 студија
- Los Angeles, CA73 студија
- Edison, NJ70 студија
- Queens, NY67 студија
- Durham, NC63 студија
- Chicago, IL59 студија
- Dallas, TX54 студија
- Philadelphia, PA51 студија
- Arlington, VA50 студија
Ostale studije u gradu St. Louis
- Немалоклетни карцином плућа68 студија
- Метастатски карцином52 студија
- Рак (све врсте)51 студија
- Колоректални карцином51 студија
- Рак простате45 студија
- Рак јајника37 студија
- Рак плућа37 студија
- Рак панкреаса33 студија
- Плоскоклеточни карцином главе и врата32 студија
- Карцином ендометријума29 студија
- Многи мијелом26 студија
- Гојазност25 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.